TD Cowen analyst Joseph Thome has maintained their neutral stance on ALLK stock, giving a Hold rating today. Joseph Thome has given his Hold rating due to a combination of factors related to the ...
Good morning, and welcome to MannKind Corporation's investor call to discuss a clinical trial update. As a reminder, this call is being recorded on November 10, 2025, and will be available for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback